Article PDF
Avoid common mistakes on your manuscript.
References
Kimberlin CL, Winterstein AG. Expert and consumer evaluation of consumer medication information—2008. http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ReportsBudgets/UCM163783.pdf. Published November 4, 2008.
Aker J, Beck M, Papay JI, et al. Consumers better understand and prefer simplified written drug information: an evaluation of 2 novel formats versus the current CMI. Therapeutic Innovation & Regulatory Science. 2013;47(1):125–132.
Bui D, Nakamura C, Bray BE, Zeng-Treitler Q. Automated illustration of patients instructions. AMIA Annu Symp Proc. 2012;2012:1158–1167.
Chan AH, Chan KW. Effects of prospective-user factors and sign design features on guessability of pharmaceutical pictograms. Patient Educ Couns. 2013;90(2):268–275.
Dowse R, Ramela T, Barford K, Browne S. Developing visual images for communicating information about antiretroviral side effects to a low-literate population. Afr J AIDS Res. 2010;9(3):213–224.
Kassam R, Vaillancourt LR, Collins JB. Pictographic instructions for medications: do different cultures interpret them accurately? Int J Pharm Pract. 2004;12(4):199–209.
Raynor DK, Dickinson D. Key principles to guide development of consumer medicine information—content analysis of information design texts. Ann Pharmacother. 2009;43(4):700–706.
Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783–801.
Wilson EA, Wolf MS. Working memory and the design of health materials: a cognitive factors perspective. Patient Educ Couns. 2009;74(3):318–322.
Wolf MS, Davis TC, Bass PF, et al. Improving prescription drug warnings to promote patient comprehension. Arch Int Med. 2010;170(1):50–56.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pearsall, B.M., Araojo, R. FDA Studies New Strategies for Presentation of Patient Information. Ther Innov Regul Sci 48, NP3–NP4 (2014). https://doi.org/10.1177/2168479013488881
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479013488881